Latest Breaking News On - Terms of the partnership - Page 1 : comparemela.com

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, headquartered in Holon, Israel, to exclusively license its potential first-in-class, pre-clinical antibody .

Foster cityUnited statesIsrael generalSan franciscoTel avivFlavius martinCompugen ltdGilead public affairsSecurities exchangeGilead sciences incTel aviv stock exchangeExchange commissionRights to later stage developmentTerms of the partnershipGilead sciencesGilead will have exclusive rights

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tel avivUnited statesSan franciscoFoster cityIsrael generalYvonne naughtonMeaghan smithFlavius martinJacquie rossGilead sciences incGilead sciencesRights to later stage developmentTerms of the partnershipExchange commissionCompugen ltdGilead public affairs

Compugen : 6K-License Agreement with Gilead and entitlement to receive a milestone payment of $10 million from AstraZeneca -December 19, 2023 at 07:24 am EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF.

United statesTel avivIsrael generalSan franciscoFoster cityYvonne naughtonJacquie rossMeaghan smithFlavius martinCompugen ltd nasdaqTel aviv stock exchangeClinical immunotherapy programGilead sciencesExchange commissionCompugen ltdCorporate communications

Gilead Sciences (GILD) and Assembly Biosciences (ASMB) Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases

Gilead Sciences (GILD) and Assembly Biosciences (ASMB) Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJason okazakiWilson sonsiniTomas cihlarGilead sciences incAssembly biosciences incVirology researchTerms of the partnershipExchange commissionMizuho securities united statesBofa securities incAssembly bioAssembly bio board of directorsGilead sciencesAssembly biosciencesSenior vice president

Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases

Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFoster cityShannon ryanWilson sonsiniTomas cihlarJason okazakiJacquie rossMeaghan smithMizuho securities united statesCorporate affairsAssembly bioAssembly biosciencesSam brown incAssembly bio board of directorsGilead sciences incGilead sciences